Live Breaking News & Updates on Clinical Stage Neumora Therapeutics

Odyssey Therapeutics raised $168 million in Series B financing, the largest round of funding for a biotech startup this week. Companies developing new technologies in genetic diseases, cancer, and drug research are represented also represented in this week’s recap of life science financings. ....

United States , Gary Glick , Mablink Bioscience , Oschner Health , Obatala Sciences , Deerfield Management Company , Clinical Stage Neumora Therapeutics , Odyssey Therapeutics , Boston Based Odyssey , Ascidian Therapeutics , Ochre Bio , United Kingdom Based , Matchpoint Therapeutics , Atlas Ventures , Access Biotechnology , France Based Mablink , Sofinnova Partners , San Diego Based , Management Company , New Orleans Based , Venture Capital , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , Medcity News ,